Programmable probiotics for detection of cancer in urine
Rapid advances in the forward engineering of genetic circuitry in living cells has positioned synthetic biology as a potential means to solve numerous biomedical problems, including disease diagnosis and therapy. One challenge in exploiting synthetic biology for translational applications is to engi...
| Main Authors: | , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | en_US |
| Published: |
American Association for the Advancement of Science (AAAS)
2015
|
| Online Access: | http://hdl.handle.net/1721.1/99876 https://orcid.org/0000-0002-1293-2097 https://orcid.org/0000-0001-7302-4394 |
| _version_ | 1811091633025843200 |
|---|---|
| author | Danino, Tal Prindle, Arthur Kwong, Gabriel A. Skalak, Matthew T. Li, Howard Hasty, Jeff Allen, Kaitlin N. Bhatia, Sangeeta N |
| author2 | Massachusetts Institute of Technology. Institute for Medical Engineering & Science |
| author_facet | Massachusetts Institute of Technology. Institute for Medical Engineering & Science Danino, Tal Prindle, Arthur Kwong, Gabriel A. Skalak, Matthew T. Li, Howard Hasty, Jeff Allen, Kaitlin N. Bhatia, Sangeeta N |
| author_sort | Danino, Tal |
| collection | MIT |
| description | Rapid advances in the forward engineering of genetic circuitry in living cells has positioned synthetic biology as a potential means to solve numerous biomedical problems, including disease diagnosis and therapy. One challenge in exploiting synthetic biology for translational applications is to engineer microbes that are well tolerated by patients and seamlessly integrate with existing clinical methods. We use the safe and widely used probiotic Escherichia coli Nissle 1917 to develop an orally administered diagnostic that can noninvasively indicate the presence of liver metastasis by producing easily detectable signals in urine. Our microbial diagnostic generated a high-contrast urine signal through selective expansion in liver metastases (10[superscript 6]-fold enrichment) and high expression of a lacZ reporter maintained by engineering a stable plasmid system. The lacZ reporter cleaves a substrate to produce a small molecule that can be detected in urine. E. coli Nissle 1917 robustly colonized tumor tissue in rodent models of liver metastasis after oral delivery but did not colonize healthy organs or fibrotic liver tissue. We saw no deleterious health effects on the mice for more than 12 months after oral delivery. Our results demonstrate that probiotics can be programmed to safely and selectively deliver synthetic gene circuits to diseased tissue microenvironments in vivo. |
| first_indexed | 2024-09-23T15:05:28Z |
| format | Article |
| id | mit-1721.1/99876 |
| institution | Massachusetts Institute of Technology |
| language | en_US |
| last_indexed | 2024-09-23T15:05:28Z |
| publishDate | 2015 |
| publisher | American Association for the Advancement of Science (AAAS) |
| record_format | dspace |
| spelling | mit-1721.1/998762022-10-02T00:29:57Z Programmable probiotics for detection of cancer in urine Danino, Tal Prindle, Arthur Kwong, Gabriel A. Skalak, Matthew T. Li, Howard Hasty, Jeff Allen, Kaitlin N. Bhatia, Sangeeta N Massachusetts Institute of Technology. Institute for Medical Engineering & Science Harvard University--MIT Division of Health Sciences and Technology Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science Koch Institute for Integrative Cancer Research at MIT Danino, Tal Kwong, Gabriel A. Skalak, Matthew T. Allen, Kaitlin Bhatia, Sangeeta N. Rapid advances in the forward engineering of genetic circuitry in living cells has positioned synthetic biology as a potential means to solve numerous biomedical problems, including disease diagnosis and therapy. One challenge in exploiting synthetic biology for translational applications is to engineer microbes that are well tolerated by patients and seamlessly integrate with existing clinical methods. We use the safe and widely used probiotic Escherichia coli Nissle 1917 to develop an orally administered diagnostic that can noninvasively indicate the presence of liver metastasis by producing easily detectable signals in urine. Our microbial diagnostic generated a high-contrast urine signal through selective expansion in liver metastases (10[superscript 6]-fold enrichment) and high expression of a lacZ reporter maintained by engineering a stable plasmid system. The lacZ reporter cleaves a substrate to produce a small molecule that can be detected in urine. E. coli Nissle 1917 robustly colonized tumor tissue in rodent models of liver metastasis after oral delivery but did not colonize healthy organs or fibrotic liver tissue. We saw no deleterious health effects on the mice for more than 12 months after oral delivery. Our results demonstrate that probiotics can be programmed to safely and selectively deliver synthetic gene circuits to diseased tissue microenvironments in vivo. Ludwig Center for Molecular Oncology Amar G. Bose Research Grant San Diego Center for Systems Biology (United States. National Institutes of Health Grant P50 GM085764) National Institute of General Medical Sciences (U.S.) (R01GM69811) National Cancer Institute (U.S.) (Koch Institute Support (Core) Grant P30-CA14051) National Institute of Environmental Health Sciences (Core Center Grant P30-ES002109) Misrock Foundation (Postdoctoral Fellowship) National Institutes of Health (U.S.) (Ruth L. Kirschstein National Research Service Award) Burroughs Wellcome Fund (Career Award at the Scientific Interface) 2015-11-10T15:24:37Z 2015-11-10T15:24:37Z 2015-05 2014-11 Article http://purl.org/eprint/type/JournalArticle 1946-6234 1946-6242 http://hdl.handle.net/1721.1/99876 Danino, T., A. Prindle, G. A. Kwong, M. Skalak, H. Li, K. Allen, J. Hasty, and S. N. Bhatia. “Programmable Probiotics for Detection of Cancer in Urine.” Science Translational Medicine 7, no. 289 (May 27, 2015): 289ra84–289ra84. https://orcid.org/0000-0002-1293-2097 https://orcid.org/0000-0001-7302-4394 en_US http://dx.doi.org/10.1126/scitranslmed.aaa3519 Science Translational Medicine Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. application/pdf American Association for the Advancement of Science (AAAS) PMC |
| spellingShingle | Danino, Tal Prindle, Arthur Kwong, Gabriel A. Skalak, Matthew T. Li, Howard Hasty, Jeff Allen, Kaitlin N. Bhatia, Sangeeta N Programmable probiotics for detection of cancer in urine |
| title | Programmable probiotics for detection of cancer in urine |
| title_full | Programmable probiotics for detection of cancer in urine |
| title_fullStr | Programmable probiotics for detection of cancer in urine |
| title_full_unstemmed | Programmable probiotics for detection of cancer in urine |
| title_short | Programmable probiotics for detection of cancer in urine |
| title_sort | programmable probiotics for detection of cancer in urine |
| url | http://hdl.handle.net/1721.1/99876 https://orcid.org/0000-0002-1293-2097 https://orcid.org/0000-0001-7302-4394 |
| work_keys_str_mv | AT daninotal programmableprobioticsfordetectionofcancerinurine AT prindlearthur programmableprobioticsfordetectionofcancerinurine AT kwonggabriela programmableprobioticsfordetectionofcancerinurine AT skalakmatthewt programmableprobioticsfordetectionofcancerinurine AT lihoward programmableprobioticsfordetectionofcancerinurine AT hastyjeff programmableprobioticsfordetectionofcancerinurine AT allenkaitlinn programmableprobioticsfordetectionofcancerinurine AT bhatiasangeetan programmableprobioticsfordetectionofcancerinurine |